8 news items
Shareholder Letter from Lior Tal, CEO at Cyngn Inc.
CYN
31 May 24
responsibility as CEO is to do what is in the best interest of the company's stakeholders, including its shareholders, employees and customers. To survive
Cyngn Scales Up Commercialization of Autonomous Vehicle Solutions in First Quarter 2024
CYN
16 May 24
is not responsible for the contents of third-party websites
Cyngn Announces Exercise and Closing of Underwriter's Over-Allotment Option
CYN
3 May 24
on such websites is not incorporated by reference into this press release. Cyngn is not responsible for the contents of third-party websites
Cyngn Announces Closing of $5.0 Million Firm Commitment Public Offering of Common Stock
CYN
25 Apr 24
as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Cyngn is not responsible
Cyngn Announces Pricing of $5.0 Million Firm Commitment Public Offering of Common Stock
CYN
23 Apr 24
is not incorporated by reference into this press release. Cyngn is not responsible for the contents of third-party websites
3ft68nie 71rtzc5h7jj74qd1
ABEO
AZTR
BE
23 Apr 24
the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment
wkdq2dbsy71 rojh90movah56r0o7qtkoqw
ABEO
CYN
JBLU
23 Apr 24
. (NASDAQ:ABEO) were down 49% to $3.7799 after the company announced the FDA issued a Complete Response Letter in response
p4imn54ajxlgtq7vdl2j9d6tly
ABEO
CYN
GWAV
23 Apr 24
issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients
- Prev
- 1
- Next